The forecast for sold production of antisera and vaccines in Poland is set to decrease from 1.6157 million Euros in 2024 to 1.4733 million Euros in 2028. The year-on-year percentage variations indicate a steady decline: 2024 to 2025 (-2.27%), 2025 to 2026 (-2.28%), 2026 to 2027 (-2.28%), and 2027 to 2028 (-2.29%). The compound annual growth rate (CAGR) over the five-year period is -2.27%.
Future trends to watch for:
- Technological advancements in vaccine development and production efficiency.
- Possible impacts of regulatory changes on production volumes.
- Changes in global and local demand driven by epidemiological factors.
- Potential partnerships and investments in the biotech sector.
